TOP STORIES

• REGULATORY New Doctor Payment Disclosure Rule to Apply to Foreign Firms with Japan Subsidiaries
  February 21, 2024

• REGULATORY Japan to End Public Aid for COVID Drugs at March-End
  February 21, 2024

• REGULATORY Xocova, Astellas’s Gastric Cancer Med Up for PAFSC Review on March 4; Pfizer’s Bispecific, RSV Jab Also on Agenda
  February 20, 2024

• BUSINESS Gilead Japan Ramping Up Sales Force with Trodelvy Now under Review
  February 20, 2024

• BUSINESS Active Pharma Hid Botched API Production, Source Reveals Details of Violations
  February 19, 2024

• BUSINESS Cancer Specialist BeiGene Set to Enter Japan Market as Early as This Year
  February 16, 2024

• BUSINESS GSK Japan Nets 11% Sales Rise in 2023, Sees 6% CAGR through 2026: President
  February 15, 2024

• REGULATORY Japan to Announce New Drug Prices on March 5
  February 15, 2024

• REGULATORY Chuikyo Issues 2024 Reform Recommendation; 1,000 Yen Premium Set for Inpatient Biosimilar Use
  February 14, 2024

• REGULATORY Japan Approves Jardiance for CKD, Label Expansion for Opdivo and More
  February 13, 2024

• BUSINESS Medac Poised to Cement Japan Foothold in RA, Eyes Rare Disease Launch Too: CEO
  February 9, 2024

• BUSINESS Mounjaro Logs 5.6 Billion Yen in Q3 YTD despite Curbed Shipments: Mitsubishi
  February 8, 2024

• REGULATORY Generic Panel to Issue Report in Spring-Summer to Drive Manufacturing Efficiency towards Stable Supplies: Official
  February 8, 2024

• REGULATORY Legal Changes on Horizon for GMP Inspection Authorities, Other Regulation Panel Topics?
  February 7, 2024

• BUSINESS 2,000 Patients Receiving Leqembi in US, 4 Times the Number on Wait List: Eisai
  February 7, 2024

• REGULATORY AMED Needs More Manpower to Fulfill Its Role as Funding Agency: President
  February 6, 2024

• BUSINESS Sumitomo to Reinforce Restructuring to Fight Deficit, First in North America: President
  February 6, 2024

• REGULATORY Truvada Clears Preliminary Review for PrEP Use, but Coverage Not Granted
  February 6, 2024

• REGULATORY Will Truvada Win Health Coverage as Japan’s First Drug for HIV Prevention?
  February 5, 2024

• BUSINESS Chugai’s 2023 Earnings Slip as Ronapreve Wanes, but Sales Still Top 1 Trillion Yen
  February 2, 2024

ページ

• « 先頭
• ‹ Prev
• …
• 46
• 47
• 48
• 49
• 50
• 51
• 52
• 53
• 54
• …
• Next ›
• 最終 »